The gene encoding the tissue speci®c transcription factor HNF1a is expressed in vertebrates in tissues of endodermal origin such as the liver and the gut as well as in the kidney, a mesoderm derived organ. Using a 6 kb HNF1a promoter fragment linked to GFP we observed green¯uorescence in transgenic embryos restricted to the liver and gut as well as to the pronephros, the embryonic kidney. By deletion and mutation analysis of the HNF1a promoter we succeeded in dissecting the HNF1a promoter into two entities that are either active in the endoderm or the mesoderm. In conclusion, our data establish that the generation of transgenic Xenopus allows the functional dissection of promoters in the context of the entire organism. q
Introduction
In the developing organism the activity of a tissue speci®c transcription factor is laid down in a well de®ned pattern that involves the regulated expression of the corresponding promoter. An approach to elucidate the molecular mechanisms involved in this process consists of de®ning the promoter elements mediating the tissue speci®c activation of the gene during embryonic development. To achieve this goal, promoter constructs may be inserted into the developing organism and their activity monitored depending on the promoter context. Such approaches have been widely used in the murine system by introducing promoter reporter constructs as transgenes into the germ line. However, these techniques require an extensive breeding facility and are therefore quite expensive and time consuming to analyze the various elements of a given promoter in a detailed fashion. As basic principles involved in developmental gene activation are conserved to a large degree during evolution, one may analyze these processes in lower vertebrate species.
Xenopus is a most attractive model to analyze the mechanisms of early development in vertebrates, as in this amphibian species the development occurs outside of the female and thus can easily be observed and manipulated (Gurdon, 1992; Dawid, 1994; Dawid and Brown, 1996) . Furthermore, embryos are available in large amounts and require a relatively low need of infrastructure for breeding. Recently, the attractiveness of Xenopus has been further increased by a method to generate transgenic frogs. The novel procedure (Kroll and Amaya, 1996; Amaya and Kroll, 1998) uses isolated sperm nuclei as the carrier of the transgene. Brie¯y, puri®ed sperm nuclei are incubated with the DNA in the presence of very limiting amounts of a restriction enzyme and the chromatin is decondensed by adding egg extracts. The swollen nuclei are injected into unfertilized eggs leading to cleavage and normal development. The method is in principle very ef®cient resulting in many transgenic embryos (Slack, 1996; Smith, 1996) .
Previously, we have characterized the gene encoding the Xenopus transcription factor HNF1a that is expressed in organs of endodermal origin, i.e. the liver and the digestive tract, as well as in the mesoderm derived kidney (Weber et al., 1996a,b; Pogge v Standmann et al., 1997) . This tissue speci®c expression pattern is identical to the mammalian homologue (reviewed in Cereghini, 1996) .
We have shown that the Xenopus HNF1a gene is transcriptionally activated shortly after midblastula transition when zygotic gene transcription starts (Bartkowski et al., 1993; Nastos et al., 1998 ). The initially very low level of expression is increased dramatically at later stages of embryonic development and HNF1a expression predominates in the pronephros, the initial type of kidney, but is also seen in a lower level in the liver and gut of the developing larvae (Weber et al., 1996a) . To determine the regulatory elements required for embryonic activation of the HNF1a gene, we injected HNF1a promoter-CAT constructs into fertilized Xenopus eggs and followed the expression of these reporters in dissected larvae (Zapp et al., 1993a) . Using this approach we succeeded in de®ning the minimal promoter required for embryonic activation of the injected reporter in the middle section of the larvae. As this part of the larvae contains the pronephros, liver and gut known to express HNF1a endogenously, we have assumed proper activation of the injected promoter CAT construct in the developing larvae. The minimal promoter construct needed to get faithful expression of the injected gene is bounded at the 5 H end (i.e. 2594 bp upstream of the translation initiation site) by an OZ element that has been found in other promoters to be required for embryonic activation of genes injected into fertilized eggs (Ovsenek et al., 1992) and at the 3 H end (2207) by the major transcription start site (Zapp et al., 1993a) . By introducing point mutations into the minimal promoter we have shown that the HNF4 and HNF1 binding sites are both required for full activation of the injected gene (Holewa et al., 1996) . As the transcription factor HNF4 is encoded in Xenopus in two genes (a and b) that are expressed as maternal components in the egg (Holewa et al., 1996; Holewa et al., 1997) , we anticipate that both of these transcription factors play a crucial role in the initial phase of embryonic activation of the HNF1a gene.
The functional analysis of promoter constructs in Xenopus as done in these previous experiments has a major drawback, as the injected gene is rarely integrated into the genome and distributed in a highly mosaic fashion (Andres et al., 1984; Mayor et al., 1993; Kroll and Amaya, 1996) . This precludes a more detailed analysis to de®ne the organs expressing the injected gene.
Using the novel strategy to introduce reporter constructs as stable transgenes into Xenopus we have now dissected the Xenopus HNF1a promoter in such a way as to de®ne distinct elements required for endodermal or mesodermal expression in the developing embryo.
Results

Tissue speci®c expression in transgenic Xenopus
Using the recently developed technique for generating stable transgenics in Xenopus (Amaya and Kroll, 1998; Kroll and Amaya, 1996) we created Xenopus larvae that are derived from unfertilized eggs upon sperm nuclei injection. After rigorous standardization of the protocol we succeeded to produce transgenic Xenopus in a reproducible fashion. From 2000 eggs injected with swollen sperm nuclei we recovered about 100±400 eggs with normal cleavage.
From these early stage embryos 30±60% will reach the larval stage 36 (staging according to Nieuwkoop and Faber, 1975) and about 10±40 normal feeding larvae (stage 45) can be obtained.
To evaluate this protocol for transgenesis in Xenopus, we initially used the CMV promoter in front of the green¯uor-escence protein (GFP) as a transgene. Fig. 1A demonstrates a developing embryo (upper part at daylight illumination) that shows a universal and homogenous expression of GFP under¯uorescence light (lower part). The green¯uores-cence persists throughout development (panel B) and is still present in the metamorphosed frog (not shown). Panel C shows that in the translucent larvae the internal organs can be seen in green (e.g. brain and pronephros). Typically also the lens is green. This green pattern re¯ects the ubiquitous activity of the CMV promoter.
To explore whether this assay allows the analysis of the expression of tissue restricted promoters, we made transgenics in Xenopus by using GFP constructs under the control of either the muscle actin or the neural b-tubulin promoter. Transgenics with muscle actin promoters give larvae with GFP positive developing myotomes (panel D). This¯uorescence persists throughout further development (panel E) and can also be seen in the eye muscles (panel F).
As an alternative we also used the neural b-tubulin promoter to direct tissue speci®c expression of the GFP gene in transgenic Xenopus: at early stages of development green¯uor-escence is seen in the neural tube (panel G) and at later stages reporter expression is found in the developing brain (panel H). The intensity of the green¯uorescence is quite weak in these transgenics and has to be carefully analyzed, as there is some¯uorescence in non-transgenic animals as well. As an example panel I depicts a neural b-tubulin transgene with genuine¯uorescence in the brain and background¯uorescence in the gut. As a comparison the transgenic larvae expressing GFP under control of the muscle actin promoter shown in Fig. 1F never show any green uorescence in the brain. Based on these experiments we conclude that the Xenopus system is most valuable to identify the functional performance of promoters of tissue speci®cally expressed genes in the living organism.
A large fragment of the HNF1a promoter is required to get tissue restricted expression in transgenic Xenopus
To evaluate the activity of the HNF1a promoter in transgenic Xenopus, we used a HNF1a promoter fragment extending from 26 kbp to 258 bp from the translation start point to direct GFP reporter expression. Using this (26 kb/258)-GFP construct we observed in the developing transgenic animals GFP activity in the liver and endodermal yolk mass as early as the neural tube stage (Fig. 2, panel A) . The expression intensi®ed in the tail bud stage embryo (stage 26) with a characteristic lack of expression in the central ventral region (panel B). As soon as the pronephros anlage differ-entiates into the lumenized structure (stage 33), this organ was clearly GFP positive (panel C as overview and panel D and E as close-ups). At later stages, when the pronephros was usually the most green part of the developing transgenic larvae (panel D and E), both the liver diverticulum (panel D) and the yolky gut region (panel E) frequently were GFP positive. However, the GFP signal in the gut had to be carefully analyzed, as this part of the embryo gives considerable green auto¯uorescence in the course of development (see also above Fig. 1I ). Fig. 2G shows in the same view a control larva (top) and HNF1a promoter transgene (bottom): clearly, the green¯uorescence signal in the control is much weaker than in the transgenic larva at stage 39. In the feeding larva (stage 46) green¯uorescence is present in the pronephros, whereas the signal in the liver and the intestine was close to background level (Fig. 2F ). The high auto¯uorescence in the liver and intestine starting at around stage 36 precludes a sensitive assay in these organs at this late developmental stage. In contrast auto¯uorescence in the pronephros never occurs in control larvae lacking any GFP transgene. Based on this fact we scored GFP expression at later stages (starting at stage 36) only in the pronephros region. The summary given in Table 1 includes stage 36 larvae of normal appearance as well as those with distorted shape as long as the head, tail and pronephros were clearly identi®able. Using the (26 kb/ 258)-GFP construct about 40% of the stage 36 larvae were GFP positive in the pronephros. In the 32 surviving feeding larvae (stage 45) 56% contained a GFP positive pronephros ( Table 1 ). All these animals scored as positive showed green uorescence in the pronephros on both sides and include the 20% of the animals that were GFP positive already at stage 20 to 28.
In conclusion, these data establish that the 6 kb promoter fragment from 26 kb to 258 of the HNF1a promoter is suf®cient to mediate expression restricted to the liver, the yolky mass of the endoderm as well as to the pronephros. This expression pattern re¯ects the activity of the endogenous gene (Weber et al., 1996a,b) .
To analyze whether the HNF1a promoter segment from 2594 to 258 that we have previously shown to mediate expression in the middle section of larvae derived from injected fertilized eggs (Zapp et al., 1993a) , is also suf®cient for tissue speci®c expression in the developing transgenic embryos, we generated transgenics with this short HNF1a promoter fragment in front of the GFP reporter. As Fig. 3 illustrates, transgenics containing the short HNF1a promoter fragment (2595/258)-GFP showed in early stages (stage 26) a rather broad expression throughout the entire embryo: In the embryo of panel A some preference is seen in the dorsal region, whereas a broader green¯uorescence is present in the animal of panel B. Typically with this short HNF1a promoter construct strong expression was frequently restricted to single cells (panel D) . This mosaic expression was only transient. As similar expression patterns were seen by injecting DNA into fertilized eggs, we assume that it re¯ects the expression of the non-integrated reporter DNA that is always coinjected in excess with the sperm nuclei into unfertilized eggs. Beside this broader expression pattern at early stages we found in advanced developing stages green¯uorescence in the pronephros, but no expression in the liver and the gut (panel C). In a few animals expression was also seen in addition in the eye (panel E). Although the performance of the short promoter construct was usually weak, larvae with prominent expression restricted to the pronephros (panel F) were frequently obtained (Table 1 ). This result implies that the short promoter fragment 2594/258 is suf®cient to mediate expression in the pronephros, but also leads to a broad expression of the transgene throughout the entire embryo. More importantly, as the short HNF1a promoter construct frequently showed transient mosaic expression and stable expression in places where the endogenous gene is inactive (Weber et al., 1996a) , we conclude that the (2594/ 258)-GFP construct is not suf®cient to get faithful HNF1a expression in the transgenic animals.
Deletion of the 3
H part of the conserved promoter fragment of the HNF1a promoter restricts expression to the pronephros in the transgenic animals
The promoter construct (26 kb/258)-GFP of the Xenopus HNF1a gene includes at its 3 H end sequences that are downstream of the major transcription start site and are highly identical to the corresponding segments of the mammalian promoter (Zapp et al., 1993a) . To elucidate the signi®cance of this area, we used the construct (26 kb/2207)-GFP that terminates 9 bp downstream of the transcription start site at 2216. Using this construct we failed to see any expression in the liver and gut region of 73 transgenics in the tailbud stage (stages 20±28), but observed green¯uorescence restricted to the pronephros in about 60% of these larvae ( Fig. 4A and Table 1 ). Obviously, this promoter fragment was suf®cient to mediate pronephros speci®c expression but did not allow expression in the liver and gut. In agreement with our observation that using the (5) a Summary of the injection experiments using the HNF1a promoter GFP reporters. Endodermal expression refers to GFP signals in the liver and yolky mass of the endoderm in stage 20 to 28 embryos. Mesodermal expression represents GFP in the pronephros. Abnormal animals at stage 36 contain malformations that still allow unambigous identi®cation of the pronephros.
b In these animals ubiquitous background expression is observed (see Fig. 3A ,B).
construct (26 kb/258)-GFP expression in the pronephros is late, the construct (26 kb/2207)-GFP was active only at late stages of development (Table 1) .
The HNF4 binding site of the HNF1a promoter is essential for pronephros speci®c expression
To analyze whether the HNF4 binding site of the HNF1a promoter plays a role in the transgenic reporters we mutated this site in the (26 kb/258) HNF1a promoter construct and introduced this (26 kb/258)mtH4-GFP construct into developing Xenopus embryos as transgene. At early stages (late neurulae to tailbud stages) we observed GFP expression in 10% of the animals in the liver and the yolky endoderm region (Table 1 ). An example of such an animal is given in Fig. 4B and the GFP expression remained in the endodermal region up to the stage 36 (panel C). However, at the time the pronephros is well differentiated no GFP expression was found in the pronephros (Fig. 4C) . As summarized in Table 1 scoring 88 normal and 73 abnormal larvae at stage 36 none of the animals expressed GFP in the pronephros. The absence of pronephros speci®c expression was con®rmed at the stage of the feeding larvae (stage 45) where none of 59 young tadpoles showed GFP in the pronephros. Possibly at this late stage GFP expression still occurs in some animals in the liver and the gut but cannot be detected due to the auto¯uorescence in these organs.
Using the reporter construct (26 kb/2207)mtH4-GFP that corresponds to the reporter (26 kb/2207)-GFP but contains a mutated HNF4 binding site we observed no GFP expression at all (Fig. 4D and Table 1 ). The absence at early stages is consistent with the lack of expression observed with the (26 kb/2207)-GFP construct and the inactivity at stages 36 and 45 con®rms that the mutated HNF4 binding site abolishes pronephros expression of the transgene. 
Discussion
As the HNF1a gene is expressed in the pronephros, a mesodermal derivative, as well as in the liver and the gut, two organs of endodermal origin, we determined the elements involved in the expression in these two different germ layers. Fig. 5 summarizes the major ®ndings of our promoter analysis in developing transgenic Xenopus as shown in Table 1 : the construct (26 kb/258)-GFP is active in endodermal as well as mesodermal derivatives, whereas the promoter construct (26 kb/2207)-GFP is never active in the endoderm of the embryos but retains activity in the mesoderm. Thus we conclude that the region between 2207 and 258 is an essential part of the promoter to mediate the endodermal expression of HNF1a. This region contains a segment of about 40 bp that is highly conserved between Xenopus and mammalian promoters and thus may represent the element essential for endodermal expression. In fact this region has been reported to contain an HNF3 (fork head) binding site in the murine gene (B2-site in Kuo et al., 1992) and several members of these transcription factors are known to be expressed during Xenopus embryogenesis (Kaufmann and Kno Èchel, 1996; Lef et al., 1996) . However, we failed to show any transactivation of a Xenopus promoter containing the homologous region by an expression clone encoding HNF3a (Zapp et al., 1993a) . As mutation of the HNF4 binding site of the HNF1a promoter reduces only slightly the activity in the endoderm (compare in Fig. 5 (26 kb/258)-GFP with (26 kb/258)mtH4-GFP), we conclude that the HNF4 binding site is not essential for the endodermal expression. In contrast, this HNF4 binding site is absolutely essential for the expression of the HNF1a promoter in the pronephros. This holds true for the (26 kb/ 258)-GFP as well as the (26 kb/2207)-GFP construct (Fig.  5) . The importance of the HNF4 binding site of the HNF1a promoter has been documented in humans, as a mutated HNF4 binding site in the promoter leads to maturity onset of diabetes in the young (MODY3) with clinical features identical to nonsense mutations in the open reading frame of HNF1a (Gragnoli et al., 1997) .
We succeeded in dissecting the HNF1a promoter in such a way that it is expressed either in endodermal or mesodermal derivatives. This dissection of the expression pattern maintains its speci®city as we have not observed any expression in other tissues. Furthermore, the temporal expression pattern is also retained, as endodermal expression is always early (starting at stage 20) and mesodermal activation late at the time the pronephros gets luminized (starting at stage 33). This means that endodermal and mesodermal expression of the HNF1a promoter are two events that can be uncoupled. This ®nding correlates with the fact that endodermal and mesodermal cells are separated well before high levels of HNF1a expression occur. Germ layer speci®c elements have also been identi®ed in the Xsna (Xenopus homologue of the Drosophila snail) promoter (Mayor et al., 1993) . In this case a promoter element (2112 to 245) is suf®cient for mesodermal and neural fold expression and a shorter fragment (296 to 245) leads to neural fold expression exclusively. However, no construct restricted in its expression to the mesoderm has been reported. In addition, these experiments were made by injecting promoter constructs into fertilized eggs leading to a highly mosaic expression pattern.
Previously, we have analyzed the functional performance of the HNF1a promoter by injecting CAT constructs into the fertilized egg. Using this approach we could de®ne a short promoter element extending from 2594 to 2207 that is suf®cient for preferential activation of the injected reporter in the middle part of dissected stage 36 larvae (Holewa et al., 1996) . In these experiments the DNA was mainly not integrated into the genome and expressed in a highly mosaic fashion. Using now the short promoter construct (2594/ 258)-GFP for transgenics in Xenopus we observed an unusual broad expression in the tailbud embryo (Fig.  3A,B) , but this expression is transient and ef®cient expression is seen at later stages predominantly restricted to the pronephros with low activity found occasionally in the eye (Fig. 3E ). Thus in a dissected larvae most of the introduced gene would be active in the middle part of the larvae and thus the result obtained is in agreement with our previous ®ndings with the CAT construct injected into the fertilized eggs. We assume that measuring the CAT activity of injected constructs involved possibly also expression in the endoderm, but the level was too low to contribute significantly. Therefore, the deletion of the fragment from 258 to 2207 precluded a signi®cant change in CAT activity in Fig. 5 . Summary of the functional performance of the HNF1a promoter GFP constructs in transgenic Xenopus larvae. The data given in Table 1 are summarized by scoring in percent the GFP positive stage 20±28 embryos that show GFP expression in the liver and the yolky mass of the endoderm as well as the pronephros of the stage 36 embryos (normal and abnormal. The structure of the HNF1a promoter GFP constructs is schematically given. The (2594/2207)-GFP construct is not included as it is not faithfully expressed (Fig. 3) . these experiments. This gives further support for the value of the new protocol to make transgenics in Xenopus.
Using the novel protocol to produce transgenic Xenopus we succeeded to generate Xenopus larvae that express a GFP reporter under the control of the HNF1a promoter in a tissue restricted manner that corresponds to the activity of the endogenous gene. The HNF1a promoter transgene is expressed initially in the endodermal derivatives, the liver primordium and the yolky endodermal cell mass that differentiates into the gut. At later stages expression can be found in the developing pronephros region that represents an organ of mesodermal origin. Transgene expression can be visualized in the living organism and its changes can be monitored during development. Due to the auto¯uorescence of the liver and gut that emerges at later stages of development a reliable analysis cannot be made in well advanced larval stages. To overcome this limitation, we tried to used a BFP (blue¯uorescence protein) reporter. However, this reporter shows a much lower activity and at the wavelength used for uorescence analysis extensive auto¯uorescence is also seen in the endoderm (data not shown). As an alternative we performed whole-mount in situ hybridization with an antisense GFP probe. This method gave considerable background in the endodermal tissues and thus does not represent a useful alternative (data not shown). In contrast, the analysis in the pronephros is most sensitive as this organ has no auto¯uorescence. Furthermore, the pronephros is located outside of the belly coat and can be identi®ed easily in well advanced developmental stages such as feeding larvae.
The current technique to produce transgenic Xenopus yields few healthy feeding larvae from the successful cleavage stages (11% on the average in the experiments given in Table 1 ). However, substantially more of the developing larvae can be used to evaluate the performance of a given promoter construct, as differentiated organs can be clearly identi®ed also in many distorted embryos and larvae. In fact, from the properly cleaved eggs we could evaluate on the average 46% and 42% at stage 20±28 and stage 36, respectively.
Our data with the HNF1a promoter con®rm the usefulness of the new technique to make transgenic Xenopus in characterizing tissue speci®c gene control. So far the promoters of the muscle actin (Kroll and Amaya, 1996) , the neural b-tubulin (Amaya and Kroll, 1998) , the lens speci®c g-crystalline and the retina speci®c rhodopsin (Knox et al., 1998) have been shown to be expressed in a tissue speci®c way as transgenic constructs. But in none of these promoter constructs the elements required for speci®c expression has been de®ned so far.
In principle the generation of stable transgenic strains of Xenopus is feasible, as some larvae reach the feeding tadpole stage and can be raised through metamorphosis to froglets (our unpublished data and Huang et al., 1999) . Unfortunately the generation time of 1±2 years in Xenopus laevis precludes multi-generation experiments in a reasonable time frame. However, the related species Xenopus tropicalis with a generation time of 4±6 months seems to be an attractive alternative .
Experimental procedures
Plasmid constructions
The GFP reporter plasmid pCSGFP2 was kindly provided by Dr. Enrique Amaya and does contain a GFP variant that is expressed under the control of the CMV promoter and contains the F64L and the S65T mutations resulting in 35 times brighter green emission (Ikawa et al., 1999) . The reporter CAR-GFP and NbT-GFP containing the muscle actin and the b-tubulin promoter, respectively, were obtained from Dr. Kristen Kroll.
The GFP constructs containing segments of the Xenopus HNF1a promoter were generated by replacing the CMV promoter (SalI-HindIII fragment) of the pCSGFP2 plasmid by the Xenopus promoter. The (26 kb/258)-GFP construct contains the 5 H EcoRI fragment of the genomic clone XLF 4b (Zapp et al., 1993b) linked to the EcoRI±HindIII fragment of the promoter clone 5D594 (Zapp et al., 1993a) . By this strategy the sequence from 26 kbp to 258 bp upstream of the translation initiation codon of the HNF1a gene is linked to the GFP reporter present in pCSGFP2. The (26 kb/2207)-GFP construct is derived from the (26 kb/258)-GFP construct by replacing the EcoRI±HindIII fragment (2494 to 258) with the corresponding EcoRI±HindIII fragment (2494 to 2207) of the 3D207 clone (Zapp et al., 1993a) . The (26 kb/258)mtH4-GFP and the (26 kb/ 2207)mtH4-GFP construct contain the mutated HNF4 binding site mut1 as described (Holewa et al., 1996) . The (2594/258)-GFP construct contains the promoter sequence of the construct 5D594 (Zapp et al., 1993b) .
Generating transgenic Xenopus
The protocol for transgenesis was essentially as described (Kroll and Amaya, 1996; Amaya and Kroll, 1998) . In our hands injection needles with diameters of 100 mm were essential to get normal development at high frequency. Due to the holes made by these large needles yolk material will leak out and usually at these positions some cells will partially protrude during development. These protrusions are minor malformations and frequently fall of at later stages. The survival was also much better by raising the transgenics at 15±178C for the ®rst 4±6 days. The plasmid used for transgenesis was linearized by NotI digestion, extracted by phenol-chloroform and extensively washed in ethanol. Four microlitres sperm nuclei, prepared the day before injection and diluted to 100 nuclei/nl, were incubated with 5 ml plasmid DNA (0.5 or 1 mg) for 5 min. 0.5 or 1 unit NotI enzyme, 2 ml 100 mM MgCl 2 and 25 ml egg high speed extract were added carefully. After 10 min 3 ml of the mixture was diluted with 330 ml sperm dilution buffer and 16 ml 100 mM MgCl 2 to get 1 sperm nucleus per 10 nl injection volume. This mixture was used for 30±40 min with two or three ®llings of the needles. All these manipulations and solutions were at room temperature. The eggs were freshly squeezed out of a female frog, dejellied in 2.5% cysteine, extensively washed in 1£ MMR and transferred to an agarose coated dish precooled to 158C that contained 0.4 £ MMR with 6% Ficoll. Each GFP construct of the HNF1a promoter was puri®ed from at least two independent preparations and the transgenic protocol was performed with 0.5 or 1 mg of DNA with 0.5 or 1 unit of NotI enzyme in the sperm nuclei incubation. This range of DNA and enzyme did not yield any signi®cant difference in the survival of embryos or the percentage of GFP expressing larvae, and thus the values are combined in Table 1 .
The embryos and larvae were analyzed with either the Leica stereomicroscope MZ12 equipped with the GFP plus¯uorescence module or the Leica MZ FLIII stereomicroscope. The¯uorescence analysis was done by using the GFP plus ®lter set (480/40 nm excitation and 510 nm barrier ®lter). The pictures made with the Leica stereomicroscope MZ12 (Figs. 1 and 3 ) are done at normal light with the ®lters for¯uorescence and therefore the colour of the larvae in normal light is yellowish. In contrast the pictures given in Figs. 2 and 4 are made with the Leica MZ FLIII stereomicroscope that allows easy ®lter changes and thus the normal light pictures are made without any ®lter. The pictures were taken with the Kappa camera CF 15/4 MC(C) (KAPPA messtechnik GmbH, D-37130 Gleichen) using exposure times between 0.2 and 1 s and 1 and 4 s for the MZ FLIII and MZ12 stereomicroscopes, respectively. For photography at advanced stages of development the larvae were anaesthetized in 0.01% 3-aminobenzoic acid ethyl ester (Sigma A5040).
